The cancer center continues to expand its business and tech bench as it seeks to speed the discovery of new cures
June 29, 2017
| By Jonathan Rabinovitz / Fred Hutch News Service
Fred Hutchinson Cancer Research Center welcomed three new members to its board of trustees yesterday, adding expertise in information technology, media and global health. The new trustees — Robert Herbold, Phil Kent and Leigh Morgan — have served, respectively, as executive vice president and chief operating officer at Microsoft Corp.; chairman and CEO at Turner Broadcasting System Inc.; and chief operating officer of the Bill & Melinda Gates Foundation.
Dr. Eduardo Méndez has received a five-year, $2.2 million grant from the National Institutes of Health to develop the first targeted therapy that they hope will be effective for most patients with head and neck cancers.
Dr. Lily Selim receives inaugural CTI BioPharma International Postdoctoral Research Fellowship; Kiem Lab scientists, associates will give 8 presentations at ASGCT conference; Nicole Robinson, VP of Industry Relations and Business Development, a GeekWire Award finalist
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.